Anxiety, Health Education, Prostate Cancer, Screening, Screening and Brief Interventions, Wellbeing
Conditions
Keywords
Prostate cancer screening, Health education workshop, anxiety, Early screening uptake
Brief summary
Prostate cancer is an issue of significant public health concern. Yet in low- and middle-income countries like Nigeria, men are adversely affected due to factors including poor early prostate cancer screening uptake. Yet a gap remains in addressing this urgent problem. The proposed study seeks to pilot the feasibility and acceptability of a novel co-produced workshop intervention called "proState Cancer awareness education to pRomote Early screENing uptake (SCREEN) with men who are not or partially up to date with their screening. The SCREEN intervention is designed to raise awareness of prostate cancer, its symptoms, implications for late screening, the benefits of early screening, avenues for screening uptake, and also addressing anxiety related to screening uptake. The SCREEN intervention is low-intensity and lasts approximately two hours. The proposed study also aims to pilot and test the instrument to determine its effectiveness and cost-effectiveness, including the mechanism by which the intervention might work.
Interventions
BEHAVIORALproState Cancer awareness education to pRomote Early screENing uptake
The SCREEN intervention is designed to raise awareness of prostate cancer, its symptoms, implications for late screening, the benefits of early screening, avenues for screening uptake, and also addressing anxiety related to screening uptake. The SCREEN intervention is low-intensity and lasts approximately two hours.
OTHERControl group
Existing information provided by health care provider, including media around prostate cancer.
Sponsors
Teesside University
Jos University Teaching Hospital
University of Manchester
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
MALE
Age
18 Years to 70 Years
Healthy volunteers
Yes
Inclusion criteria
* Men aged between age 18 years and 79 who are not or partially up to date with prostate cancer * Able to provide full consent for their participation. * Able to speak the English Language. Able to take part in the intervention and are available for the intervention assessment at baseline and end of intervention.
Exclusion criteria
* Less than 18 years * Unable to consent. * Currently undergoing severe mental health treatment. * Unable to speak the English language * not meeting the inclusion criteria.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Service Satisfaction Scale | At the end of intervention (day 2) | A five item scale that can be used to assess and measure satisfaction, acceptability and quality of the intervention. Higher score denote positive outcomes and acceptability. Lower score denotes poor satisfaction and acceptability. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Oslo Social Support Scale (OSSS-3) | Baseline (day 1) and at the end of intervention (day 2) | The scale is a 3-item self-reported measure designed for assessing and measuring the level of social support. The sum score ranges from 3 to 14, with high values representing strong levels and low values representing poor levels of social support as indicated as follows: a) 3-8 poor social support, b) 9-11 moderate social support, c) 12-14 strong social support. |
| Generalised Anxiety Disorder (GAD-7) | Baseline (day 1) and at the end of intervention (day 2)] | The GAD-7 is a seven item scale for screening, measuring and assessing the severity of generalised anxiety disorder. Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively. |
| Knowledge of prostate cancer and screening scale | Baseline (day 1) and at the end of intervention (day 2)] | 14 item scale that measures knowledge of Prostate Cancer (PC). The 14 items on the PC knowledge scale is scored according to whether or not the participants responded correctly to each question, and the total number of correct responses will be calculated ranging from 0 to 14, with higher scores indicating higher PC knowledge. |
| Beliefs around prostate cancer and screening intention scale | Baseline (day 1) and at the end of intervention (day 2) | A 5-item scale that measure beliefs around prostate cancer and intention to engage in screening. Score range from 0-25 with lower score denoting strong willingness to engage in early screening uptake. |
| Intention to test for prostate cancer scale | Baseline (day 1) and at the end of intervention (day 2) | The scale assesses the intention to take a PSA test among men when this test is: (i) offered by a doctor or (ii) based on the men's own initiative. It also predicts which attitudes (beliefs, outcomes), subjective norms (opinions of significant others, own motivation) and perceived control (obstacles, facilitating factors) are the most important for taking a PSA test. Lower total scores mean a stronger and more determined intention to undergo prostate cancer screening. Higher scores indicate low or absent readiness to complete the test. |
| European Quality of Life Scale EQ-5D-5L | Baseline (day 1) and at the end of intervention (day 2) | The EQ-5D-5L is a 5 item scale designed to aid assessment of the generic quality of life. In the EQ-5D-5L, each dimension has five response levels: no problems (Level 1); slight (Level 2); moderate (Level 3); severe (Level 4); and extreme problems (Level 5). There are 3,125 possible health states defined by combining one level from each dimension, ranging from 11111 (full health) to 55555 (worst health). |
Contacts
CONTACTTarela J Ike, Dr
CONTACTDung E Jidong, PhD
Outcome results
None listed